Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
27.93
-1.02 (-3.52%)
Aug 14, 2026, 1:00 PM EDT - Market open
Pelthos Therapeutics Revenue
Pelthos Therapeutics had revenue of $15.60M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $43.30M. In the year 2025, Pelthos Therapeutics had annual revenue of $16.80M.
Revenue (ttm)
$43.30M
Revenue Growth
n/a
P/S Ratio
2.32
Revenue / Employee
$470,696
Employees
92
Market Cap
97.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.80M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
PTHS News
- 1 day ago - Pelthos Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Pelthos Therapeutics Earnings release: Q2 2026 - Filings
- 1 day ago - Pelthos Therapeutics Quarterly report: Q2 2026 - Filings
- 1 day ago - Pelthos Therapeutics Slides: Corporate presentation - Filings
- 1 day ago - Pelthos Therapeutics Announces Second Quarter 2026 Financial Results - GlobeNewsWire
- 7 days ago - Pelthos Therapeutics Proxy statement: Proxy filing - Filings
- 11 days ago - Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026 - GlobeNewsWire
- 20 days ago - Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders - GlobeNewsWire